Abound Wealth Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $759 | Buy |
+5
| New | +$759 | ﹤0.01% | 822 |
|
|
2025
Q1 | – | Sell |
-2
| Closed | -$338 | – | 1259 |
|
|
2024
Q4 | $338 | Buy |
2
+1
| +100% | +$169 | ﹤0.01% | 862 |
|
|
2024
Q3 | $243 | Hold |
1
| – | – | ﹤0.01% | 1058 |
|
|
2024
Q2 | $255 | Hold |
1
| – | – | ﹤0.01% | 1031 |
|
|
2024
Q1 | $334 | Buy |
+1
| New | +$334 | ﹤0.01% | 1083 |
|
|
2023
Q4 | – | Sell |
-10
| Closed | -$1.96K | – | 1369 |
|
|
2023
Q3 | $1.96K | Sell |
10
-1
| -9% | -$196 | ﹤0.01% | 620 |
|
|
2023
Q2 | $2.31K | Buy |
11
+1
| +10% | +$210 | ﹤0.01% | 624 |
|
|
2023
Q1 | $2.02K | Buy |
+10
| New | +$2.02K | ﹤0.01% | 587 |
|